Despite increased serum IL-17 levels and increased cutaneous IL-17A expression in SLE patients, few IL-17-producing T lymphocytes are found in DLE lesions, suggesting a less important role in this clinical manifestation.16 The gene discussed is IL17A; the disease is systemic lupus erythematosus.